Zura Bio Ltd — Director's Dealing 2023

Jun 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zura Bio Ltd (ZURA)
CIK: 0001855644
Period of Report: 2023-06-01

Reporting Person: Munshi Amit (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-01	Employee Share Option (Right to Buy)	$6.25	A	1130000	Acquired	2033-06-01	Class A Ordinary Shares (1130000)	Direct

Footnotes

F1: The Reporting Person was granted an option to purchase 1,130,000 Class A Ordinary Shares of the Issuer (the "Option") on June 1, 2023 (the "Grant Date"). The Option is vested and nonforfeitable as of the Grant Date. 25% of the Option shall become exercisable on June 1, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter.